Figure legends
Figure 1. Inter- and intraindividual variability of serum concentrations and daily dose of atomoxetine in various CYP2D6/2C19 genotype subgroups. A and B: The effect of CYP2D6 genotype subgroups not carrying (N ) or carrying the CYP2C19*2 allele variant (*2 ) on serum concentration (A) and daily dose (B) of atomoxetine. This effect was analysed using linear mixed model without covariates with CYP2D6 NM not carrying CYP2C19*2 allele variant as reference group. *P-values <0.05, and the p-values are Sidak-adjusted. The various CYP2D6 genotype subgroups are represented with red dots for poor metabolizers (PM), yellow dots for intermediate metabolizers (IM), green dots for normal metabolizers (NM) and blue dots for ultra-rapid metabolizers (UM), respectively.